UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study

The Journal of infectious diseases, 2010-09, Vol.202 (5), p.717-722

2010

Volltextzugriff (PDF)

African potato (Hypoxis hemerocallidea): a systematic review of its chemistry, pharmacology and ethno medicinal properties

BMC complementary medicine and therapies, 2020-06, Vol.20 (1), p.1-12, Article 182

2020

Volltextzugriff (PDF)

Interactions between Buprenorphine and Antiretrovirals. I. The Nonnucleoside Reverse-Transcriptase Inhibitors Efavirenz and Delavirdine

Clinical infectious diseases, 2006-12, Vol.43 (Supplement-4), p.S224-S234

2006

Volltextzugriff (PDF)

Pharmacokinetic Interactions between Buprenorphine and Antiretroviral Medications

Clinical infectious diseases, 2006-12, Vol.43 (Supplement-4), p.S216-S223

2006

Volltextzugriff (PDF)

Interactions between Buprenorphine and Antiretrovirals. II. The Protease Inhibitors Nelfinavir, Lopinavir/Ritonavir, and Ritonavir

Clinical infectious diseases, 2006-12, Vol.43 (Supplement-4), p.S235-S246

2006

Volltextzugriff (PDF)

Cross-validation of a high-performance liquid chromatography nevirapine plasma assay in a resource-limited setting in Zimbabwe

African journal of laboratory medicine, 2021, Vol.10 (1), p.e1-e5

2021

Volltextzugriff (PDF)

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants

Pharmacogenetics and genomics, 2012-12, Vol.22 (12), p.858-867

2012

Volltextzugriff (PDF)

In vitro Pharmacokinetic Cell Culture System that Simulates Physiologic Drug and Nanoparticle Exposure to Macrophages

Pharmaceutical research, 2019-03, Vol.36 (3), p.44-8, Article 44

2019

Volltextzugriff (PDF)

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

Journal of antimicrobial chemotherapy, 2014-08, Vol.69 (8), p.2175-2182

2014

Volltextzugriff (PDF)

A Randomized Trial of 2 Different 4-Drug Antiretroviral Regimens versus a 3-Drug Regimen, in Advanced Human Immunodeficiency Virus Disease

The Journal of infectious diseases, 2003-09, Vol.188 (5), p.625-634

2003

Volltextzugriff (PDF)

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202

Pharmacogenetics and genomics, 2014-04, Vol.24 (4), p.195-203

2014

Volltextzugriff (PDF)

EDITORIAL COMMENTARY: Malaria and HIV/AIDS Interaction in Ugandan Children

Clinical infectious diseases, 2016-08, Vol.63 (3), p.423-424

2016

Volltextzugriff (PDF)

Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s

Antiviral therapy, 2018-01, Vol.23 (4), p.345-351

2018

Volltextzugriff (PDF)

Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s

British journal of clinical pharmacology, 2020-01, Vol.86 (1), p.132-142

2020

Volltextzugriff (PDF)

Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202

Pharmacogenetics and genomics, 2015-09, Vol.25 (9), p.450-461

2015

Volltextzugriff (PDF)

Effect of Moringa oleifera Lam. leaf powder on the pharmacokinetics of nevirapine in HIV-infected adults: a one sequence cross-over study

AIDS research and therapy, 2017-03, Vol.14 (1), p.12-12, Article 12

2017

Volltextzugriff (PDF)

Translational pharmacology and HIV reservoir eradication strategies

Future virology, 2017-11, Vol.12 (11), p.631-633

2017

Volltextzugriff (PDF)

Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir

Clinical infectious diseases, 2012-02, Vol.54 (3), p.414-423

2012

Volltextzugriff (PDF)

Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy

Journal of antimicrobial chemotherapy, 2014-05, Vol.69 (5), p.1370-1376

2014

Volltextzugriff (PDF)

Disulfiram metabolite S-methyl-N,N-diethylthiocarbamate quantitation in human plasma with reverse phase ultra performance liquid chromatography and mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012-05, Vol.897, p.80-84

2012

Volltextzugriff (PDF)

Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s

Drugs in R&D, 2017-12, Vol.17 (4), p.557-567

2017

Volltextzugriff (PDF)

Emerging nanomedicine approaches to targeting HIV-1 and antiretroviral therapy

Future virology, 2016-02, Vol.11 (2), p.101-104

2016

Volltextzugriff (PDF)

A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients

AIDS (London), 2009-01, Vol.23 (3), p.357-368

2009

Volltextzugriff (PDF)

Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir

Journal of acquired immune deficiency syndromes (1999), 2010-08, Vol.54 (5), p.511-514

2010

Volltextzugriff (PDF)

Within-Patient Atazanavir Trough Concentration Monitoring in HIV-1-Infected Patients

Journal of pharmacy practice, 2011-04, Vol.24 (2), p.216-222

2011

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

ThemaPharmacokinetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study

African potato (Hypoxis hemerocallidea): a systematic review of its chemistry, pharmacology and ethno medicinal properties

Interactions between Buprenorphine and Antiretrovirals. I. The Nonnucleoside Reverse-Transcriptase Inhibitors Efavirenz and Delavirdine

Pharmacokinetic Interactions between Buprenorphine and Antiretroviral Medications

Interactions between Buprenorphine and Antiretrovirals. II. The Protease Inhibitors Nelfinavir, Lopinavir/Ritonavir, and Ritonavir

Cross-validation of a high-performance liquid chromatography nevirapine plasma assay in a resource-limited setting in Zimbabwe

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants

In vitro Pharmacokinetic Cell Culture System that Simulates Physiologic Drug and Nanoparticle Exposure to Macrophages

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

A Randomized Trial of 2 Different 4-Drug Antiretroviral Regimens versus a 3-Drug Regimen, in Advanced Human Immunodeficiency Virus Disease

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202

EDITORIAL COMMENTARY: Malaria and HIV/AIDS Interaction in Ugandan Children

Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s

Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s

Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202

Effect of Moringa oleifera Lam. leaf powder on the pharmacokinetics of nevirapine in HIV-infected adults: a one sequence cross-over study

Translational pharmacology and HIV reservoir eradication strategies

Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir

Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy

Disulfiram metabolite S-methyl-N,N-diethylthiocarbamate quantitation in human plasma with reverse phase ultra performance liquid chromatography and mass spectrometry

Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s

Emerging nanomedicine approaches to targeting HIV-1 and antiretroviral therapy

A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients

Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir

Within-Patient Atazanavir Trough Concentration Monitoring in HIV-1-Infected Patients

Aktive Filter

Suchergebnisse filtern